Testing for PlGF levels can predict the risk of early-onset preeclampsia during pregnancy in people with sickle cell disease, ...

In honor of her 39th birthday, columnist Oluwatosin Adesoye reflects on the lessons she's learned from living with sickle ...

Tocilizumab was effectively used off-label in four young adults with sickle cell disease (SCD) to treat hyperhemolysis ...

Fewer Black men with SCD are biological parents compared with similarly aged Black men in the overall U.S. population, data ...

Columnist Mary Shaniqua offers up ideas for managing sickle cell disease to get the most out of busy end-of-year events.

The European Medicines Agency (EMA) has confirmed the continuing suspension of marketing authorization for Pfizer’s sickle cell disease (SCD) treatment Oxbryta (voxelotor) — withdrawn from the market ...

It's time for equal care for sickle cell patients, writes columnist. That means ending the systemic bias in treatment.

Young people with sickle cell disease (SCD) who live in areas with more air pollution are more likely to be hospitalized due to acute chest syndrome (ACS), an SCD complication marked by symptoms that ...

One of the most widely discussed symptoms of sickle cell anemia is a sickle cell crisis. This is an episode of pain caused when sickle-shaped red blood cells block the body’s blood vessels and prevent ...

A first targeted treatment for sickle cell disease (SCD) — Adakveo (crizanlizumab), by Novartis, that works to lower the frequency of the painful vaso-occlusive crises (VOCs) common in this disease — ...